Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel Pudendal Block in Vaginal Prolapse Surgery
NCT03664986Phase 4Unknown
- Sponsor
- Atlantic Health System
- Start
- Sep 2018
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of liposomal bupivacaine in postoperative pain (2 arms), sponsored by Atlantic Health System. Primary endpoint: Pain on postoperative day one. Status: unknown.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03664986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03664986.